Serum immunoglobulin levels in children with respiratory infections who used a synbiotic dietary supplement ORIGINALNI RAD / ORIGINAL ARTICLE Nivo imunoglobulina u serumu u dece obolele od respiratornih infekcija i lečene sinbiotikom
INTRODUCTION
Probiotics are living microorganisms that favorable act at human health. Favorable act of probiotic is emphasized by prebiotic in synbiotic (1) . Together they modulate mucosal and systemic immunity and improve nutritive and microbiota balance in an intestinal tract. 2 During the same time probiotics inhibits proliferation of pathogenic bacteria and can help prevention of pathogenic infections. 3, 4 Probiotic causes an initial mild enteral inflammation which activates dendritic cells to stimulate NK-cells and macrophages and the end protects against infection. Bifidobacteria (BifB.) from probiotics increase levels of anti-inflammatory cytokine IL10 and IFN-gamma and immunoglobulins G, A and M and decrease levels of IL-4 and pro-inflammatory cytokines (IL-1beta, IL-6, TNF-alpha, IL-8, NFkB, IL-12) and immunoglobulin E. 5, 6, 7 Actually, BifB and lactobacillus rhamnosus GG (LGG) from probiotic immunomodulation seems with inhibition of immunoglobulin E(IgE) production. Probiotic makes immunomodulation and establishes mucosal tolerance that means inhibition of toll-like receptors 3 and 1, CD4, CD25, then high expression of toll-like receptors 2 and 9, CD83, development of tolerogenic dendritic cells and increasing of level of TGF-beta and IL-10 and PGE2. 8 Also, probiotics contribute to maturing gut barrier and rise level of calprotectin and alpha-1-atitrypsin. 9, 10, 11 BifB stimulate production of IL-10 and expression of CD83 that both inhibit releasing of Th2 cells cytokines.
At birth, baby has production of BifB and low level of Lactobacilli opposite lot of E.coli and Enterococci what got average fecal pH 6. Very soon fecal pH falls at 4,5-5 because very fast production of Bacteroides, Peptococcus and Clostridium. In adult and elderly level of BifB falls and level of Clostridia rises that made increased of faecal pH to 6-7,5. During immunity answer to infective agent first increase level of IL-2, INF-gama and IL-8.
In fetus with atopic heredity we can find prenatal proliferation of mononuclear cells to houst dust mites, activity of toll-like receptors is low and we find low level of IL-6 but high level of IFN-gamma that contribute developing of pre-existing inflammation. Pre-existing inflammation can mean pre-existing asthma particularly in condition of smoking during pregnancy and fetal passive smoking. 13, 14, 15 Immunoglobulin G(IgG) in atopic child is blocking antibody in inflamed mucosa and doesn't bind to mast cells. Immunoglobulin A(IgA) covers mucosal surface and inhibit attachment of microbes 10 and high it level reduces the risk of IgE allergic disease. Against this, non-atopic infant has very early colonization with Bifidobacterium as breast feeding infants.
The purpose of this study was to investigate the effectiveness and the optimal time of supplementation with synbiotic in atopic children with common respiratory and/or ear infections. The children are fed daily at a dose preparation of synbiotic (Lactobacillus helveticus Rosell-52, Bifidobacterium infantis Rosell-33, Bifidobacterium bifidus Rosell-71 and fructo-oligosaccharides 750mg).
PATIENTS AND METHODS
We recruited inpatients children that couldn't be treat of respiratory infection in primary care health but hospitalized. During hospitalization they are selected using method unintentional sample, by respiratory infection and/or ear infection, by atopic status and by low level of immunoglobulins(Ig), particular IgA. In the same time their infections have been adequate treated and we established their immunologic state. After hospitalization treatment was followed by synbiotic during 3 or 6 months and we observed clinical features and level of immunoglobulins, particular IgA. Synbiotic was prescribe once a day, every 3 months IgA level was determined and in accordance with the outcome decided the termination or continuation of supplementation with synbiotics.
Atopic status are estimated by allergy skin prick test and graduated as high, low and no-atopics. The children who show sensitization with induration greater than 8 mm in total or each allergens (dermatophagoides pteronyssinus, mold, cockroach, cat, hair, latex, hornet, plumage, house dust, tree pollens, weeds pollens, grass pollens, dog hair, yellow egg, milk, seafood, peanut, cacao, kiwi, pork meat, rice, lemon, spinach, white egg, chicken meat, wheat flour) have the high atopic status. The children who show sensitization with induration less than 7 mm in total or each allergens have low atopic status. Childrens are non-atopics if have not sensitazation to each of 25 allergens.
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RESULTS
We recruited 31 inpatients children aged 6 to 42 months hospitalized because respiratory infections. Their average age was 19 months (Xav=19±19, p<0,05). They were group of children with equal distribution by gender, 16(52%) boys and 15(48%) girls (figures 1 and 2). During hospitalization we established that 14 children (45%) suffer from pneumonia, 8 (26%) suffer from middle ear infection and 23(74%) suffer from pharyngitis. We found concomitant infections in 5(16%) of patients (laryngitis in 1(3%), sepsis in 2(6%), urinary tract infection in 2(6%) patients) and concomitant diseases (anemia in 8(26%), enlarge adenoids in 2(6%), eczema in 4(13%), wheezing bronchitis in 5(16%), bronchial asthma in 13(42%), urticaria in 1(3%) patients). Data are shown at figure 3. By allergy skin prick test we estimated that 16 (52%) children are high atopics and 9 (32%) children are low atopics what is total 25 children (81%). Non-atopic are 6 (19%) children (figure 3). We estimated that a sample size of 31 patients would be needed to obtain data at the 5% significance level with 90% power, assuming on 2SD. Time was included as a categorical parameter and using analysis of covariance. Covariates used for analyses, where applicable , were age, sex, atopic status and kind of illness. It was calculated confidence limits.
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treatment by synbiotic isn't significant (t=0,43, P<0,05) but after 3 months treatment with synbiotic as after 6 months treatment no one child suffers from respiratory infections what is important clinical finding.
DISCUSSION
A meta-analysis collecting studies published during last decade (13) show that the potential field of application of probiotics is wide but still not thoroughly clarified, it was confirmed a real beneficial and immune-modulating effect of probiotics in some allergic and respiratory illnesses according to specific strain and the appropriate time. Our intention was to clarify optimal duration of treatment with synbiotic and our finding is at least 6 months.
Consistent changes were seen in the treatment kind of illness and level of immunoglobulins suggesting deficiency of humoral immunity. At fact, we found low level of protective immunoglobulin A in all young children average age of 19 months and every second child (58%) showed deficiency of IgG. Level of IgM is normal in 94% studied children that suffer from respiratory infections. Every second child average age of 19 months suffers, at the same time, from pneumonia (45%) and deficiency of humoral immunity. Every fourth child suffers, at the same time, from middle ear infection (26%) and deficiency of humoral immunity. In every fourth child we established, at the same time, anemia (26%) and deficiency of humoral immunity. Wheezing disorders (as wheezing bronchitis and bronchial asthma), are established in every second child (n=18 or 58%) old 19 months, who, at the same time, suffer from deficiency of humoral immunity and respiratory infections needed to treat in hospital.
Concomitant infections (laryngitis, sepsis, urinary tract infection) was found in every 6 child (16%), average old 19 months, with deficiency of immunoglobulin A and G. It is well known that children reach normal values of immunoglobulins by the end first year of life.
After 3 months of treatment with synbiotic every third child (35%) acquired normal level of IgA and after 6 months of same treatment 81% children acquired normal level of IgA. This dates means that synbiotic is very effective in solving of deficiency of IgA and IgG and following respiratory infections but duration of supplementation of synbiotic must be the shortest 6 months. Important clinical improvement was found after 3 months of supplementation with synbiotics so that no child is sick from an infection (respiratory, sepsis, inflammation of the middle ear).
Influence of many environmental and microbes agents during the first 3-4 years of life are known to affect immune system particular respiratory immunity, lung and airways development, possible evolution of asthma and allergy, probable pharyngitis, possible pneumonia, middle ear infection and anemia. These early influences on the respiratory system in young children result to burden of respiratory and hematologic diseases followed by deficiency of humoral immunity. With atopic children immunity answer to infective agents is in keeping with down-regulation of eosinophil and mast cells. We showed that synbiotic respectively probiotic takes right place for the successful control of respiratory infections in atopic young children.
In atopic children immunity answer to infective agents is in keeping with down-regulation of eosinophil and mast cells. Disbalance of intestinal microbiota and local intestinal deficit of IgA influence to law level of respiratory IgA in atopic children what is reason for frequent respiratory and other, possible severe infections, and anemia, then their long-time of duration. Our intention was to clarify optimal duration of treatment with synbiotic and we confirm that it is at least 6 months. We emphasize that we have already achieved clinical improvement after 3 months of supplementation with synbiotic. Synbiotic reduce the risk of common infectious disease in young, atopic, children.
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